Board director Carol Ashe resigns from Aptose Biosciences, effective immediately

Aptose Biosciences Inc.

Carol Ashe resigned from the Board of Aptose Biosciences effective June 16, 2025.
Resignation not due to any disagreement with the company's operations, policies, or practices.
No replacement director named in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Carol Ashe

member of the Board

APTOF · Aptose Biosciences Inc.

Effective: 2025-06-16
Filed: June 18, 2025, 7:59 PM ET

On June 16, 2025, Carol Ashe notified the Board of Directors (the “Board”) of Aptose Biosciences Inc. (the “Company”) of her intention to resign from her role as a member of the Board effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Carol Ashe resigned as member of the Board at Aptose Biosciences Inc..

Action: resigned
Role: member of the Board

Exact text from the filing

On June 16, 2025, Carol Ashe notified the Board of Directors (the “Board”) of Aptose Biosciences Inc. (the “Company”) of her intention to resign from her role as a member of the Board effective immediately.

View on SEC.gov

Aptose Biosciences Inc. filing history →

Source: SEC EDGAR

accession 0001171843-25-003962

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.